Table 4 |
|||
|
Multivariable associations between patient characteristics and the prevalence of synovitis |
|||
| Model term |
OR |
95% CI for OR |
P value |
|
|
|||
| Gender |
|||
| Female |
1.104 |
0.279–4.659 |
1.000 |
| Male |
1 |
||
| Disease duration, years |
|||
| <1 |
1.772 |
0.416–8.270 |
0.576 |
| 1 to <2.5 |
3.926 |
0.722–25.120 |
0.133 |
| 2.5 to <6 |
0.908 |
0.176–4.711 |
1.000 |
| ≥ 6 |
1 |
||
| Age, years |
|||
| <40 |
1.423 |
0.3217–6.597 |
0.837 |
| 40 to <50 |
1.307 |
0.2818–6.179 |
0.951 |
| 50 to <60 |
1.258 |
0.205–7.421 |
1.000 |
| ≥ 60 |
1 |
||
| Anti-CCP |
|||
| Positive |
7.611 |
1.475–74.870 |
0.010 |
| Negative |
1 |
||
| SSA |
|||
| Positive |
1.588 |
0.376–7.413 |
0.691 |
| Negative |
1 |
||
| SSB |
|||
| Positive |
0.393 |
0.130–0.967 |
0.084 |
| Negative |
1 |
||
|
|
|||
|
Anti-CCP, cyclic citrullinated peptide antibody; CI, confidence interval; OR, prevalence odds ratio. |
|||
|
Atzeni et al. Arthritis Research & Therapy 2008 10:R51 doi:10.1186/ar2420 |
|||
